Extended Spectrum Beta-Lactamases (ESBL) in gram negative bacill at a Tertiary Care Hospital

Journal of Clinical and Diagnostic Research

Volumn 3, Issue 1, 2009, Pages 1307-1312

  Shobha, K L ^a   Ramachandra, L ^b   Rao, G ^a   Majumder, S ^b   Rao, S P ^b  

^a MELAKA MANIPAL MEDICAL COLLEGE   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

Author keywords

ESBL; Gram negative bacilli; Novel fashion method

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BACTERIUM MUTANT; DISK DIFFUSION; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT DEPARTMENT; PHENOTYPE; PSEUDOMONAS; SCREENING; TERTIARY HEALTH CARE;

BACILLI (CLASS); ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS;

EID: 61349097403     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Winn W.Jr, Allen S, Janda W et al. Koneman's color atlas and textbook of diagnostic microbiology. 6th edn. 2006 Philadelphia USA.
2. Amitha Jain, Indranil Roy, Mahendra K Gupta, Mala Kumar and S.K. Agarwal. Prevalence of ESBL producing gram negative bacteria in septicaemic neonates in tertiary care hospital. J Medl Microbiology 2003; 52: 421-25.
3. C. Rodrigues, P.Joshi, SH Jain, M Aiphons, R Radhakrishna, A Mehata. 2004. Detection of β lactamases in nosocomial gram negative clinical isolates. JCM. 22(4):247-50.
4. Clinical and Laboratory Standards Institute, 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Hanstia JB, Agarwal V, Patha KAA, Saoji AM. ESBL mediated resistance to 3rd generation cephalosporins in Klebsiella pneumonia, Nagpur Central India. Indian Journal of Medical Research. 1997;105:158-61.
6. Abigal S Mathai ,E Jesudasan MV,Jhon TJ: Ceftazidim resistance among Klebsiella pneumoniae in South India. Indian Journal Of Medical research. 1995:102:53-88
7. David L Peterson MD. β lactamase inhibitor and new β lactamase: JCM. 1999; 85-87
8. S Babypadmini, B Appalaraju: Extended spectrum - lactamases in urinary isolates of Escherichia coil and Klebsiella pneumoniae-Prevalence and susceptibility pattern in a tertiary care hospital: IJMM. 2004;22:3:172-74.
9. A Varaiya, J Dogra, M Kulkarni, P Bhalekar: Extended spectrum beta lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in diabetic foot infection: IJMM. 2009; 26:3:281-82.
10. Mahua Sinha, H Srinivasa and R Macaden: SBL-Production of Acinetobacter species: IJMR. 2007;126:63-67.
11. Giuseppe Celenza, Cristina Pellegrini, Marisa Caccamo, Bernardella Segatore, Gianfranco Amicosante and Mariagrazia Perilli: Spread of bla CTX- Mtype and bla PER-2 β- Lactamase genes in clinical isolates from Bolivian hospitals. Journal of Antimicrobial Chemotherapy. 2006;57(5):975-78.
12. K. Bush: Beta-lactamase inhibitors from laboratory to clinic. Clin Microbiol Rev. 1988;1(1):109-23.